Capmatinib in Japanese patients with <i>MET</i> exon 14 skipping–mutated or <i>MET</i>‐amplified advanced NSCLC: GEOMETRY mono‐1 study

Takashi Seto, Toyoaki Hida, Shunichi Sugawara et al.|Cancer Science|2021

Cited by 17